The GLP 1 receptor is a G protein coupled receptor that enhances insulin release from pancreatic beta cells in a glucose dependent manner meaning insulin secretion increases primarily when blood sugar is elevated
Both deliver tirzepatide for weight management, but regulatory status, formulation, and delivery method differ significantly
These hormones stimulate the production of insulin
Novo Nordisk recently sued the popular American telehealth company Hims & Hers Health for selling unsafe, knock-off versions of their GLP-1 medications, according to Novo Nordisk
Understanding the relationship between semaglutide therapy and skeletal health is essential for comprehensive patient care
Since then, Shannon has authored scholarly pieces in many industrious outlets including RDH Magazine, Dentistry IQ, Dimensions of Dental Hygiene and was the first dental hygienist to be published in Dentistry Today